JPRN-jRCT1050220190尚未招募Unknown
Effects of SGLT2 inhibitors on appetite in patients with type 2 diabetes
in Kazuko0 个研究点目标入组 58 人开始时间: 2023年3月14日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 58
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 20age old 至 < 85age old（—）
- 性别
- All
入选标准
- •1) Those with a diagnosis of type 2 diabetes
- •2) Persons starting SGLT2 inhibitors
- •3) Patients between 20 and 85 years of age
- •4) Patients with renal function eGFR 30 or higher
- •5) BMI of 18.5 or more
排除标准
- •1) Those undergoing treatment for cancer
- •2) Pregnant women
- •3) Those who are emotionally unstable due to mental illness, etc. and have difficulty participating in the research
- •4) Those who have difficulty in reading and understanding Japanese
- •5) Persons with dementia
- •6) Those who are judged by the attending physician or researcher to be unable to participate in the research.
研究者
相似试验
进行中（未招募）
1 期
SEESAW (SGLT-2 Inhibitor Empagliflozin Effects on Appetite and Weight Regulation)Type 2 diabetes mellitusMedDRA version: 21.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2015-001594-40-GBniversity of Leicester76
已完成
4 期
The effects of empagliflozin on appetite and weight regulation in diabeticsDiabetes mellitusSpecialty: Diabetes, Primary sub-specialty: BothUKCRC code/ Disease: Metabolic/ Diabetes mellitus, Metabolic/ Diabetes mellitusNutritional, Metabolic, EndocrineISRCTN82062639niversity of Leicester68
已完成
不适用
Efficacy and change in taste by taking SGLT2 inhibitor in patients with type 2 diabetestype 2 diabetesJPRN-UMIN000020157agasaki University Hospital60
已完成
不适用
Effect of SGLT2 inhibitor on energy metabolism in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000024822Kyoto University Graduate School of Medicine100
已完成
不适用
A study on the efficacy and biogenic adaptability affected by ipraglifloziType 2 diabetesJPRN-UMIN000015478Kobe University104